USE OF HCNP PEPTIDES FOR THE MODULATION OF CARDIO-VASCULAR PHYSIOLOGY AND DIURESIS

摘要

The present invention relates to a method of use of HCNP peptides or their derivatives or functional equivalents as active ingredients in medicaments for the modulation of cardiac physiology, diuresis as well as modification of cardiac cells cytoskeleton and/or induction of cardiac cells actin cytoskeleton modification.